• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型N-ras在体外和NOD/SCID小鼠体内均优先驱动人类CD34+造血祖细胞向髓系分化和增殖。

Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse.

作者信息

Shen Sylvie W, Dolnikov Alla, Passioura Toby, Millington Michelle, Wotherspoon Simon, Rice Alison, MacKenzie Karen L, Symonds Geoff

机构信息

Children's Cancer Institute Australia for Medical Research, Randwick, NSW, Australia.

出版信息

Exp Hematol. 2004 Sep;32(9):852-60. doi: 10.1016/j.exphem.2004.06.001.

DOI:10.1016/j.exphem.2004.06.001
PMID:15345287
Abstract

OBJECTIVES

Ras oncogene mutations are the most frequently observed genetic abnormality (20-40% of patients) in acute myeloid leukemia (AML), and in the preleukemic conditions myelodysplastic syndrome (MDS) and myeloproliferative disorder (MPD). We have previously shown that mutant N-ras (N-rasm) can induce myeloproliferative disorders and apoptosis in a murine reconstitution system. In the present study we investigated the effect of N-rasm in human primary hematopoietic progenitor cells (HPC).

METHODS

Cord blood CD34+ hematopoietic progenitor cells (HPC) were transduced with retroviral vectors containing green fluorescence protein (GFP) alone, or in combination with N-rasm. Cells were then cultured in vitro with a cytokine supplement or cocultured with murine stroma MS-5 cells. The in vivo behavior of transduced cells was examined in the NOD/SCID mouse model.

RESULTS

N-rasm-transduced cells exhibited greater proliferative capacity; a higher frequency of granulocyte-macrophage colony-forming unit (CFU-GM); and an increase in myelomonocytic lineage cells with a concomitant decrease in lymphoid and erythroid cells. Analysis of transduced HPC in NOD/SCID mice revealed higher bone marrow engraftment by N-rasm HPC and increased numbers of myeloid lineage cells.

CONCLUSIONS

The results demonstrate that N-rasm in HPC induces myeloproliferation both in vitro and in the NOD/SCID mouse model as a primary event that does not appear to be dependent on cooperating transforming events.

摘要

目的

Ras癌基因突变是急性髓系白血病(AML)以及白血病前期疾病骨髓增生异常综合征(MDS)和骨髓增殖性疾病(MPD)中最常见的基因异常(20%-40%的患者)。我们之前已经表明,突变型N-ras(N-rasm)可在小鼠重建系统中诱导骨髓增殖性疾病和细胞凋亡。在本研究中,我们调查了N-rasm对人原代造血祖细胞(HPC)的影响。

方法

用单独含有绿色荧光蛋白(GFP)或与N-rasm组合的逆转录病毒载体转导脐血CD34+造血祖细胞(HPC)。然后将细胞在含有细胞因子补充剂的体外培养,或与小鼠基质MS-5细胞共培养。在NOD/SCID小鼠模型中检查转导细胞的体内行为。

结果

转导N-rasm的细胞表现出更强的增殖能力;粒细胞-巨噬细胞集落形成单位(CFU-GM)频率更高;髓单核细胞系细胞增加,同时淋巴细胞和红细胞减少。对NOD/SCID小鼠中转导的HPC分析显示,N-rasm HPC的骨髓植入率更高,髓系细胞数量增加。

结论

结果表明,HPC中的N-rasm在体外和NOD/SCID小鼠模型中均诱导骨髓增殖,这是一个似乎不依赖于协同转化事件的主要事件。

相似文献

1
Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouse.突变型N-ras在体外和NOD/SCID小鼠体内均优先驱动人类CD34+造血祖细胞向髓系分化和增殖。
Exp Hematol. 2004 Sep;32(9):852-60. doi: 10.1016/j.exphem.2004.06.001.
2
N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.N-ras癌基因诱导人类造血祖细胞中的基因表达:p16INK4a和p21CIP1/WAF1的上调与髓系分化相关。
Exp Hematol. 2007 Jun;35(6):908-19. doi: 10.1016/j.exphem.2007.02.011.
3
Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.在NOD/SCID小鼠中,用携带人凝血因子VIII基因的基于猿猴免疫缺陷病毒agmTYO1的载体转导的人脐血来源的CD34+细胞实现持续的转基因表达。
J Gene Med. 2004 Oct;6(10):1049-60. doi: 10.1002/jgm.609.
4
Efficiency of transgenic T cell generation from gene-marked cultured human CD34+ cord blood cells is determined by their maturity and the cytokines present in the culture medium.
Gene Ther. 2000 May;7(10):830-6. doi: 10.1038/sj.gt.3301176.
5
Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.肝细胞生长因子(HGF)、血小板生成素(TPO)与早期作用细胞因子共同促使造血祖细胞向髓系和B淋巴细胞系分化。
Eur J Haematol. 2006 Aug;77(2):134-44. doi: 10.1111/j.1600-0609.2006.00673.x.
6
Decreased homing of retrovirally transduced human bone marrow CD34+ cells in the NOD/SCID mouse model.在NOD/SCID小鼠模型中,逆转录病毒转导的人骨髓CD34+细胞归巢减少。
Exp Hematol. 2006 Apr;34(4):433-42. doi: 10.1016/j.exphem.2005.12.014.
7
Enhancement of proliferation and differentiation of erythroid progenitors by co-transduction of erythropoietin receptor and H-ras cDNAS into single CD34(3+) cord blood cells.通过将促红细胞生成素受体和H-ras cDNA共转导至单个CD34(3+)脐血细胞中增强红系祖细胞的增殖和分化
Bone Marrow Transplant. 2000 Oct;26(8):817-22. doi: 10.1038/sj.bmt.1702620.
8
Cytokine-pretreatment of CD34(+) cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice.体外对CD34(+)脐血干细胞进行细胞因子预处理会降低其在NOD/SCID小鼠体内的长期细胞植入。
Eur J Cell Biol. 2008 Feb;87(2):69-80. doi: 10.1016/j.ejcb.2007.08.001. Epub 2007 Oct 10.
9
Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.在NOD-SCID小鼠股骨内移植后快速的髓系红细胞系重建揭示了一类新的人类干细胞。
Nat Med. 2003 Jul;9(7):959-63. doi: 10.1038/nm886.
10
Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation.逆转录病毒介导的将突变型H-ras基因导入正常人骨髓会改变髓样细胞的增殖和分化。
Exp Hematol. 1994 Jan;22(1):8-12.

引用本文的文献

1
The Crossroads of Clonal Evolution, Differentiation Hierarchy, and Ontogeny in Leukemia Development.白血病发展过程中克隆进化、分化层次和个体发生的交叉点
Blood Cancer Discov. 2025 Mar 4;6(2):94-109. doi: 10.1158/2643-3230.BCD-24-0235.
2
Myeloid Disease Mutations of Splicing Factor SRSF2 Cause G2-M Arrest and Skewed Differentiation of Human Hematopoietic Stem and Progenitor Cells.剪接因子 SRSF2 的骨髓疾病突变导致人类造血干/祖细胞的 G2-M 期阻滞和分化偏倚。
Stem Cells. 2018 Nov;36(11):1663-1675. doi: 10.1002/stem.2885. Epub 2018 Jul 27.
3
Oncogenic NRAS hyper-activates multiple pathways in human cord blood stem/progenitor cells and promotes myelomonocytic proliferation in vivo.
致癌性NRAS在人脐带血干细胞/祖细胞中过度激活多种信号通路,并在体内促进髓单核细胞增殖。
Am J Transl Res. 2015 Oct 15;7(10):1963-73. eCollection 2015.
4
Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation.致癌性NRAS使原发性急性髓系白血病细胞具备分化能力。
PLoS One. 2015 Apr 22;10(4):e0123181. doi: 10.1371/journal.pone.0123181. eCollection 2015.
5
Activated k-ras, but not h-ras or N-ras, regulates brain neural stem cell proliferation in a raf/rb-dependent manner.激活的k-ras而非h-ras或N-ras,以raf/rb依赖的方式调节脑内神经干细胞增殖。
Stem Cells. 2015 Jun;33(6):1998-2010. doi: 10.1002/stem.1990.
6
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias.脐带血祖细胞中 ERG 的过表达促进扩增,并再现高 ERG 白血病的分子特征。
Leukemia. 2015 Apr;29(4):819-27. doi: 10.1038/leu.2014.299. Epub 2014 Oct 13.
7
N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene.N-Ras(G12D) 诱导表达 AML1-ETO 融合基因的人类脐血白血病前培养物的逐步转化特征。
Blood. 2011 Feb 17;117(7):2237-40. doi: 10.1182/blood-2010-01-264119. Epub 2011 Jan 3.
8
KRAS(G12V) enhances proliferation and initiates myelomonocytic differentiation in human stem/progenitor cells via intrinsic and extrinsic pathways.KRAS(G12V) 通过内在和外在途径增强人类干细胞/祖细胞的增殖并启动髓系单核细胞分化。
J Biol Chem. 2011 Feb 25;286(8):6061-70. doi: 10.1074/jbc.M110.201848. Epub 2010 Dec 17.
9
Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy.致癌性 RAS 使急性髓系白血病细胞能够对化疗产生 DNA 损伤和 p53 依赖性分化。
PLoS One. 2009 Nov 5;4(11):e7768. doi: 10.1371/journal.pone.0007768.
10
Overexpression of Rheb2 enhances mouse hematopoietic progenitor cell growth while impairing stem cell repopulation.Rheb2的过表达增强了小鼠造血祖细胞的生长,同时损害了干细胞的再增殖能力。
Blood. 2009 Oct 15;114(16):3392-401. doi: 10.1182/blood-2008-12-195214. Epub 2009 Aug 18.